10.

RESTRUCTURING

In March 2012, we announced a plan to restructure our bioanalytical laboratory operations. The restructuring plan included the closure of our facility and bioanalytical laboratory in Warwickshire, United Kingdom.

As part of the restructuring, we accrued for lease payments at the cease use date for our United Kingdom facility and have considered free rent, sublease rentals and the number of days it would take to restore the space to its original condition prior to our improvements. Based on these matters, we have a $1,000 reserve for lease related costs. Additionally, we accrued $117 for legal and professional fees and other costs to remove improvements previously made to the facility. At March 31, 2017 and September 30, 2016, respectively, we have $1,117 reserved for the restructuring liability. The full restructuring reserve is classified as a current liability on the Consolidated Balance Sheets.